The consequences of climate change on human health are substantial and are now recognized as important contributors to allergic diseases. Thus, allergists and immunologists urgently need to take action to curtail its effect and modify its long-term course.
This is a preview of subscription content, access via your institution
Access options
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
M.E.R. is a consultant for Pulm One, Spoon Guru, ClostraBio, Serpin Pharm, Allakos, Celldex, Celgene, AstraZeneca, Adare/Ellodi Pharma, GlaxoSmith Kline, Regeneron/Sanofi, Revolo Biotherapeutics and Guidepoint and has an equity interest in the first six listed, and royalties from reslizumab (Teva Pharmaceuticals), PEESSv2 (Mapi Research Trust) and UpToDate. M.E.R. is an inventor of patents owned by Cincinnati Children’s Hospital.
Rights and permissions
About this article
Cite this article
Rothenberg, M.E. Linking the allergy epidemic to climate change. Nat Immunol 23, 149 (2022). https://doi.org/10.1038/s41590-021-01119-5
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41590-021-01119-5